In March 2024, the first public report on de novo antibody design using an AI tool was released in a preprint by a group led by David Baker, a pioneer in the field.

Sanyou Bio's Innovative Intelligent Antibody Design oneClick+ Platform, independently designed by Sanyou Bio, integrates 90% of the mainstream antibody structures currently available on the market ...

For Absci, criticism rained over their January 2023 preprint on bioRxiv, which described de novo antibody design for human epidermal growth factor receptor 2 (HER2), ...

More information: Richard W. Shuai et al, Generative language modeling for antibody design, bioRxiv (2022). DOI: 10.1101/2021.12.13.472419 Provided by Johns Hopkins University ...

When the COVID-19 pandemic closed down local public libraries in early 2020, another kind of library not only flourished but also proved crucial in the fight against the novel coronavirus: the ...

"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...